Menu
GeneBe

AOC1

amine oxidase copper containing 1

Basic information

Region (hg38): 7:150824626-150861504

Previous symbols: [ "ABP1", "ABP" ]

Links

ENSG00000002726NCBI:26OMIM:104610HGNC:80Uniprot:P19801AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AOC1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AOC1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
40
clinvar
3
clinvar
1
clinvar
44
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 40 5 1

Variants in AOC1

This is a list of pathogenic ClinVar variants found in the AOC1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-150856386-GCCCTAACCTGAGGGAAGCCCATCTCTGCCCATAAGACAACTAAGTTCATCTCCTCTATTGCATTCCAGAGCCGTGGAGCGAGAGATGCCGGCCCTGGGCTGGGCCGTGGCTGCCATCCTGATGCTGCAGACGGCCATGGCGGAGCCCTCCCCGGGGACTCTGCCCAGGAAGGCAGGGGTGTTTTCAGACCTAAGCAACCAAGAGCTGAAGGCAGTGCACAGCTTCCTCTGGTCCAAGAAGGAGCTGAGGCTGCAGCCCTCCAGTACCACCACCATGGCCAAGAACACCGTGTTTCTCATCGAGATGCTGCTGCCCAAGAAGTACCATGTGCTGAGGTTTCTGGATAAAGGTGAAAGGCATCCTGTGCGGGAAGCCCGTGCCGTCATCTTCTTTGGTGACCAGGAGCATCCCAATGTCACCGAGTTTGCTGTGGGGCCCCTGCCAGGGCCCTGCTACATGCGAGCACTGTCCCCCAGGCCTGGGTACCAGTCCTCCTGGGCATCGAGGCCCATCTCCACAGCAGAGTATGCCCTCCTCTACCACACCCTGCAGGAAGCCACCAAGCCCCTGCATCAGTTCTTCCTCAATACCACAGGCTTCTCATTCCAAGACTGCCATGACAGATGCCTGGCCTTCACCGATGTGGCCCCCCGGGGTGTGGCTTCTGGCCAGCGCCGCAGTTGGCTTATCATACAGCGCTATGTAGAAGGCTACTTTCTGCACCCCACTGGGCTGGAGCTCCTCGTGGATCATGGGAGCACAGATGCTGGGCACTGGGCCGTGGAGCAGGTGTGGTACAACGGGAAGTTCTATGGGAGCCCAGAGGAACTGGCTCGGAAGTATGCAGATGGAGAGGTGGACGTGGTGGTCCTGGAGGACCCGCTGCCTGGGGGCAAGGGGCATGACAGCACAGAGGAGCCGCCCCTCTTCTCCTCCCACAAGCCCCGCGGGGACTTCCCCAGCCCCATCCATGTGAGCGGCCCCCGCTTGGTCCAGCCCCACGGCCCTCGCTTCAGGCTGGAGGGCAACGCTGTGCTCTACGGCGGCTGGAGCTTTGCCTTCCGGCTGCGCTCCTCCTCCGGGCTGCAGGTCCTGAACGTGCACTTCGGCGGAGAGCGCATTGCCTATGAGGTCAGCGTGCAAGAGGCAGTGGCGCTGTATGGAGGACACACACCTGCAGGCATGCAGACCAAGTACCTCGATGTCGGCTGGGGCCTGGGCAGCGTCACTCATGAGTTAGCCCCCGGCATCGACTGCCCGGAGACCGCCACCTTCCTGGACACTTTCCACTACTATGATGCCGATGACCCGGTCCATTATCCCCGAGCCCTCTGCCTCTTTGAAATGCCCACAGGGGTGCCCCTTCGGCGGCACTTTAATTCCAACTTTAAAGGTGGCTTCAACTTCTATGCGGGGCTGAAGGGCCAGGTGCTGGTGCTGCGGACAACTTCAACTGTCTACAATTATGATTACATTTGGGACTTTATCTTCTACCCCAACGGGGTGATGGAGGCCAAGATGCATGCCACTGGCTACGTCCACGCCACCTTCTACACCCCCGAGGGGCTGCGCCACGGCACTCGCCTGCACACCCACCTGATTGGCAACATACACACTCACTTGGTGCACTACCGCGTAGACCTGGATGTGGCAGGTAGGACTCAAAGCGAGACTCTCCCGTTCAAACATCTGCATCCAGCCAATAACTTAAACTCCCAGGAGACGGCACTATAACTCCCTGGTGGTGGAAAGTTAGGAGCATTTGCCAAGCCTGCTTCTGTAAAACCTAAAGCTAGAAATTTGTGTGTCCCTGAAAAATGGTGAAAGCGAACAGTGCCGAGGGTTGCCCTGGATGCAACAGTGTGGACCCTGTCCTGACCCTGGGGCTGTGCATGGGGCAAGGGAGGGGACGGTGCCTATGAGGGTAAGAAATGTCACTGTCTAGCGCTTTGAGATGGAGTGTAGTATTGTCTGGGAATATTCAGGGTGTCTCCTGGATGATATCACCATAAAAGAATGGCATGGGTAGAATAACTAATGCTGCCAGACCCAACAAGGCCACCAGGACCACACGGGCGGCTCCTACCCCTCAGCCCCAGTCACCTCTCTGGACAGAGCCTCCCATGCCTGGAGAAAAATGGGTGCCCCTGCTCTAGGATTGCAGCCACAGCAGATGGGCATGAGCACAGCTCTTGAGAGGAACTTCCCAGAGTGGTAATGGAATCACCACAGCCGCCCAGGGCATCCCCCAACATCCCGGTTATTCAAGACAGTTGGCTGTTGGATGTGGTGGAGGATGGAGATCCTGGGGTAGAATGAGGAGGTTTCAGTTCTGGCAGCTTGATTCTCGTTCTCCTTCTCCCTGCATACCTCCAGGCACCAAGAACAGCTTCCAGACACTGCAGATGAAGCTAGAAAACATCACCAACCCCTGGAGCCCAAGACACCGCGTGGTCCAGCCAACTCTGGAGCAGACGCAGTACTCCTGGGAGCGCCAGGCGGCCTTCCGCTTCAAAAGGAAGCTGCCTAAGTACCTGCTCTTTACCAGCCCCCAGGAGAACCCCTGGGGCCACAAGCGCACGTACCGCCTGCAGATCCACTCCATGGCCGACCAGGTGCTGCCCCCAGGCTGGCAGGAGGAGCAGGCCATCACCTGGGCAAGGTGAGGAAGACCCAGGGGGCCTGGGGGAGGGTCAGTGGCTTCCCTCAGTGTGTGTGTCTGTGTCTGTCTGTGTTTGTGTCTATGGGGTTCCTAGTCTATGTGGATATACACATATACGTATGTGTATATCTGTGTGTACAATTGACCCTGAACAATATGGGGGGTAGGGGTGCCAACCCCCCAAAGCAGTAAAGAAGCCAAGTGTAACTATGACTCCCCCACAACGTAACTACGAATAGCCTACTGTTAACCGGAAGCCTTACCACTAACAGAAACATTCCGTGAACACATATTTTGTAGGTTCTGTGTGTCAGATACTGTGTTCTTACAATAAAGTAAGCTAGAGAAAAGAAAATGTTATTAATAAAATCCTGGCCGGGCACGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAAGCTGAGGCAGACAGATCACGAGGTCAGGAGATCAAGACCATCCTGGCTAACACGGTGAAACCTCATCTCTACTAAAAACACAAAAAATTAGCTGGGCATGGTGGCAGGCACCTGTAGTCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCGAGATCACACCACTGCACTCCAGTCTGGGCAACAGAGCAAGACTAGTTCTCAAAAAAAAAAAAAAAAAAATCCTAAGGAAAAGAAAATATATCTACAATCCATTAAGTGGGAGTGGCTCATCCCAAAGGTCTTTATCCTCGTCTCCTTCACTTTAAGTGGGCTGAGGAAGAGGAGGAGGAGGGGCTGGTCTTGCTGTCTCACGGTGGCAGAGGCGGAAGAAACTCCAAATGAAAGTGGACTTGTGTGCTGGGCGCAGGAGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCAAGGTGGGCAGATCACCTGAGGTCAGGAGTTCGAGACCAGCCTGGCCAACACAGCGAAACCCTGTCTCTACTAAAGATACAAAAGTTAGCCGGGTGTGGTCGTGGGCGCCTGTAATCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATCACTTGAACCTGGGAGGCAGAGGTTGCAGTGAGCCAAGATCGCATCACTGCACTCCAGCCTGGGTGACAGAGCAAAACTCCATCAAAAAAAAAGAAAAAGAAAAGAAAAGAAGGAAGGAAAGAGAGAGAAAGAGGACCCATGCAGCTCACACCTGTGTTGTGCAAGGGTTGCCTGCTGTTCTGGGCCTGTGTCTCTGTGCATTTGGGGAGGGGGGCGGGGAGGACTCCTGTGGGTCACCTGAACCCGGTTAACAGCAGCCCGTCCTGCTGACTCCCAGGACAGATGATCTGTCATCTTGGGGAAGGCAATCATCTTCCTCTATTCTGACCCTGAGGCTGTTCCCTGGGCAGGACTGAGGGGGGCCAGCCCAGGGCCCTGAGCCAAGCTGCTTCGCCTGTGCCTGGCAGGTACCCCCTGGCAGTGACCAAGTACCGGGAGTCGGAGCTGTGCAGCAGCAGCATCTACCACCAGAACGACCCCTGGCACCCGCCCGTGGTCTTTGAGCAGTTTCTTCACAACAACGAGAACATTGAAAATGAGGTACTGCCCTGTCCCCAGCCCTGCCCGGTGCTGGCCCTGCCTCCTTCCAGCTCAGCCCAGGACCATCCTCATCACCATCAGGGAGTCCCAACCACCCTTTGCCCAGATCTGTCCCCAGTCGCAGGAGCTGTGCCTTGCTGTGTGGACGGCAAGTTCAGAGGTCACAACAGAGCTGCTCATCTCTTTAAAAAGGGGCTGGAGAGGAATTCAGCAAGTTTCCAGGCAGAACTGAAAATGACCAAAGGCTAGAGTGGCCTCCAGTGGTCAGTACTCAGCCCTGCCCACTGAAGCCCACCCTGTCTCCTGCAGGACCTGGTGGCCTGGGTGACGGTGGGCTTCCTGCACATCCCCCACTCAGAGGACATTCCCAACACAGCCACACCTGGGAACTCCGTGGGCTTCCTGCTCCGGCCATTCAACTTCTTCCCAGAGGACCCCTCCCTGGCATCCAGAGACACTGTGATCGTGTGGCCTCGGGACAACGGCCCCAACTACGTCCAGCGCTGGATCCCTGAGGACAGGGACTGCTCGATGCCTCCCCCTTTTAGCTACAATGGGACCTATAGACCTGTGTGACCAGCCCCCAGTTCCTCCCCCAGTTCCTCCCAGGAAGCCCAGGAGCCTCACTGGGGCAGACAATAAACCCTCAGAGCCTCGCTCTGTGTGCTGCTTCTTGCGGGGAGGCACAGGGCCATGTGTGTAGGAAACACACGAACAGACGTGCACACACACAGACGTGCACACACACACAGACATGCACACACACACAGACGTGCACACACACAGACGTGCACGCACTCACACGGACATGCACACACATGGCATGTACTTTATTCACACTGGTCTACTGCAGTCCAGAAAAGCCACCATTACTAACAAAAAGGAAGCTCGCTGAAATCCTGCACCTATCAGATTGTTTTTTTAAAATCTGAGACTGGCCAGGCACGGTGGCTCACGCTGGTAATCCCAGCACTTTGGGAGGCTGAGACGGGAGGATGGGAGGATCACTTGAGTCCAGGAGTTCAAGACCAGCCTGAGCAACACGCTAAACCCCATCTCTCCTAAAAAATACAAAAAAAATTAGCCAGGCAGGGCAGCATACGCCTGTAGTCCTGGGGCAGAGGGGGTTAGATAGGAAGATCTCTTGAGCTGAGAAGCCGAGATCACGCCACTGCACTCCAGCCTGGGCAACACAGACACAGTGAGACCCTGTCTCAAAAAAAAAAAAAAAAAAATCTGAGAGTGACAACTTTCTCTTGGGGAGGCTGCAAGGGAATTTCCCAGTGTCAGTGACAGGCTTGCAAAATGGCACAACCATAGAGAAGATGCTACAGGGAGATCTAGCAGGATCACCATGCCTTTATCCATTGGCACACTGGCCCAACCTCAGGGGGTTTATCCCCAAGATCCACCTGTAAACACAGGAACGACATATGTACAAAGTGATTCATTGCAGCATTGTTTGTAACAGCGAAAGTCTGGAAACAACCAAATTCTCATCTGTAGAAAACCCCAATTGAATGAACTGTGGCACAACCTCACAGTGCAATTCTAGCTGATTGTAAGAGAAACACACGAATGAGGATACTCTGTGTGCTGATAGGGCAAAACTTCAGGCCATAGCAAGTAAGAAAAGAGAAGAGGCATAGAATAATACAGACAGCATGCTAACTTTGCATGAGAAAGGACAGGAGTTTCCCTAGACTGGTCTCCATGTAGACGACAGGGAAGCATGGTGGATGAGAACAGGGATAGGAGCAGGCTTTCTTCATGGAAACCTTTCTATTGAGTTGTTAGGGGTTTTGTTGTTTTGTTTGCTTGCTTTTGGGGACAGAAGGGGAATGATGGAGAGGGCCGGGCCACGGGCTGGCCAGGTAGGGAGATAGAGGCTGGGGAGAAAGCAGAGTGGCCTGGCCAGACGCTATGGGGATGGGGATGGGGCAAGGAGGGTCTCCTCCCTCCCTCTGGAGCTGAGGGAGCCCCAAGTGTCCCGGCCATGGCACATGGCCCAGGAAAGCACTAACTGCAGAAACCCAGGTGCCACAGCCTCTCGCCCCAGTGCTATGTTATTTTTATTTTTGAATCGTGAGAATGTATTACCTATTCAAAAAACTGAAATCTAAATTTTACAAGAGGGAGGAAGGGAGGAAATGAGGGAGGGAAAGAGAGAAAGAAAAATGAAACTCTAATTGCTGATGTGTGGTACTATAGTAGCTGGCCAGGATGGATGGGGTAGATAGAATAATGCCCTCCACCCCCCACTAATGATGTCCACATCCTGATCCCTGGGACCTGTGGATCTGTTACCTTACATGCACTAGGAAGGAATTCTGTGGGCATGATTAAGGTAAGGATCTTGAGATGGGAAATTATCCTGGATCATCCAGGTGGGCTTGAGTAATCACAAGGCCCTTGTGAGCGGGAGACAGGAGAGAAGAGAGGAGAGAAGATGCCACACTGCCGGCTGTGAAGATGACAGAAGGGGCCACAAGCCAAGGAATGTAAGCGACCTCTAGAAACTGGAAAAGACAAGGAAACAGATTTTCCCCTAGAGCCTCCATTAGGAACAAGGCCCTGAAGACCTCAGATGGTAAGAGAATA-G Normal pregnancy not provided (-)157080
7-150856483-G-A not specified Uncertain significance (Mar 31, 2024)3299954
7-150856528-G-A not specified Uncertain significance (Aug 28, 2021)3127353
7-150856530-G-C not specified Uncertain significance (Feb 12, 2024)3127354
7-150856538-C-T not specified Likely benign (Mar 20, 2023)2518901
7-150856540-G-A not specified Likely benign (Jul 13, 2021)2227741
7-150856541-G-A not specified Uncertain significance (Jan 29, 2024)3127355
7-150856586-A-T not specified Uncertain significance (May 12, 2024)3299974
7-150856600-G-A not specified Uncertain significance (Dec 14, 2023)3127347
7-150856675-G-A not specified Uncertain significance (May 23, 2024)3299924
7-150856762-C-T not specified Uncertain significance (Jun 11, 2024)3299918
7-150856805-C-T not specified Uncertain significance (Dec 27, 2023)3127352
7-150856957-C-T not specified Uncertain significance (Jun 18, 2024)3300000
7-150856973-A-C not specified Uncertain significance (Jun 17, 2024)3299992
7-150857060-G-A not specified Uncertain significance (Nov 05, 2021)2363188
7-150857062-C-T not specified Uncertain significance (Aug 02, 2022)2229393
7-150857078-T-C not specified Uncertain significance (Feb 09, 2023)2482593
7-150857164-G-A not specified Likely benign (Dec 01, 2022)2330527
7-150857204-G-T not specified Uncertain significance (Jun 29, 2023)2608251
7-150857228-A-T not specified Uncertain significance (Nov 10, 2022)2325619
7-150857279-G-T not specified Uncertain significance (Dec 21, 2022)2404571
7-150857308-C-T not specified Uncertain significance (Aug 30, 2021)2412464
7-150857333-G-A not specified Uncertain significance (Jun 22, 2023)2596143
7-150857351-C-T not specified Uncertain significance (Jan 02, 2024)3127357
7-150857383-C-T not specified Uncertain significance (Feb 11, 2022)2388327

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AOC1protein_codingprotein_codingENST00000493429 436878
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.72e-80.8891252550831253380.000331
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7584284740.9020.00003044887
Missense in Polyphen154175.160.879181842
Synonymous0.6751932050.9400.00001391548
Loss of Function1.681523.80.6290.00000120248

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006310.000608
Ashkenazi Jewish0.000.00
East Asian0.0007240.000723
Finnish0.00009300.0000928
European (Non-Finnish)0.0003390.000335
Middle Eastern0.0007240.000723
South Asian0.0005300.000523
Other0.0001650.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the degradation of compounds such as putrescine, histamine, spermine, and spermidine, substances involved in allergic and immune responses, cell proliferation, tissue differentiation, tumor formation, and possibly apoptosis. Placental DAO is thought to play a role in the regulation of the female reproductive function.;
Pathway
Tryptophan metabolism - Homo sapiens (human);Arginine and proline metabolism - Homo sapiens (human);Histidine metabolism - Homo sapiens (human);Tyrosinemia, transient, of the newborn;Dopamine beta-hydroxylase deficiency;Disulfiram Action Pathway;Histidine Metabolism;Tyrosine Metabolism;Alkaptonuria;Monoamine oxidase-a deficiency (MAO-A);Hawkinsinuria;Tyrosinemia Type I;Histidinemia;Tryptophan metabolism;Neutrophil degranulation;Phase I - Functionalization of compounds;Glycine Serine metabolism;Tyrosine metabolism;Biological oxidations;Innate Immune System;Immune System;Metabolism;Phenylalanine degradation;Histidine metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Arginine Proline metabolism;histamine degradation;Tryptophan degradation;Tyrosine metabolism;Histidine degradation;Glycine, serine, alanine and threonine metabolism (Consensus)

Recessive Scores

pRec
0.720

Intolerance Scores

loftool
rvis_EVS
-0.59
rvis_percentile_EVS
18.25

Haploinsufficiency Scores

pHI
0.463
hipred
N
hipred_score
0.170
ghis
0.407

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyHighMediumHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Aoc1
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
xenobiotic metabolic process;amine metabolic process;cellular response to copper ion starvation;response to drug;neutrophil degranulation;response to antibiotic;oxidation-reduction process;cellular response to copper ion;cellular response to histamine;cellular response to heparin;cellular response to azide
Cellular component
extracellular region;extracellular space;peroxisome;plasma membrane;bicellular tight junction;specific granule lumen;extracellular exosome
Molecular function
copper ion binding;calcium ion binding;primary amine oxidase activity;drug binding;heparin binding;zinc ion binding;protein homodimerization activity;protein-containing complex binding;quinone binding;diamine oxidase activity;histamine oxidase activity;methylputrescine oxidase activity;propane-1,3-diamine oxidase activity